Clofibrate and niacin in coronary heart disease

JAMA. 1975 Jan 27;231(4):360-81.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Arterial Occlusive Diseases / complications
  • Cerebrovascular Disorders / complications
  • Cholesterol / blood*
  • Clinical Trials as Topic
  • Clofibrate / administration & dosage
  • Clofibrate / pharmacology
  • Clofibrate / therapeutic use*
  • Coronary Disease / blood
  • Coronary Disease / complications
  • Coronary Disease / drug therapy*
  • Coronary Disease / mortality
  • Coronary Disease / prevention & control
  • Electrocardiography
  • Follow-Up Studies
  • Heart Failure / complications
  • Humans
  • Intermittent Claudication / complications
  • Male
  • Middle Aged
  • Nicotinic Acids / administration & dosage
  • Nicotinic Acids / pharmacology
  • Nicotinic Acids / therapeutic use*
  • Placebos
  • Time Factors
  • Triglycerides / blood*

Substances

  • Nicotinic Acids
  • Placebos
  • Triglycerides
  • Cholesterol
  • Clofibrate